Search Results 141-150 of 16374 for infliximab

  1. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    ... infliximab, adalimumab, or certolizumab pegol) per study criteria; Have screening laboratory test results within protocol-specified parameters. Exclusion ...

  2. Crohn's Disease Clinical Trials - Mayo Clinic Research

    ... Infliximab and Vedolizumab in Children with IBD Rochester, MN. This study will be a multi-center, longitudinal, observational investigation to collect ...

  3. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Treatment with infliximab, adalimumab, or etanercept within the past 12 months. Currently taking azathioprine, 6-mercaptopurine, methotrexate, mycophenolate ...

  4. Researchers FISH for Answers about Barrett's Esophagus

    Study Shows Crohn's Disease Patients Benefit From Infliximab Plus Azathioprine · Study Suggests Improved DNA Stool Test Could Detect Digestive Cancers in ...

  5. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Prior use of any TNFα antagonist including (but not limited to) infliximab, adalimumab, golimumab, certolizumab, or biosimilar agents at any time. Prior or ...

  6. Adalimumab-adbm (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-adbm injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  7. Inflammatory Bowel Disease Treatment And Response To Therapy - Mayo Clinic

    ... infliximab, certolizumab) due to loss of response, or incomplete response of current medication. Loss of response – objective flare after initial response ...

  8. Ulcerative Colitis Clinical Trials

    ... infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side ...

  9. Isatuximab-irfc (intravenous route) - Side effects & uses - Mayo Clinic

    Isatuximab-irfc injection is used in combination with pomalidomide and dexamethasone to treat multiple myeloma (a type of bone marrow cancer) in patients who ...

  10. Adalimumab-fkjp (subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Levoketoconazole; Measles Virus Vaccine, Live; Mercaptopurine; Methotrexate; Mumps Virus Vaccine, Live; Poliovirus ...